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Abstract
Introduction: Although metastatic carcinoma in the presence of an occult primary tumor is well recognized,
underlying reasons for the failure of the primary tumor to manifest are uncertain. Explanations for this
phenomenon have ranged from spontaneous regression of the primary tumor to early metastasis of the primary
tumor before manifestation of a less aggressive primary tumor. We report a case of ‘prechronous’ metastasis arising
from clear cell renal cell carcinoma, where metastatic disease initially manifested in the absence of a primary renal
tumor, followed by aggressive growth of the primary renal lesion.
Case presentation: A 43-year-old Malay man initially presented to our facility with fever and cough. He
subsequently underwent surgical resection of a 9 cm right-sided lung mass found on radiological examination.
Histology showed a high-grade clear cell tumor with sarcomatoid differentiation, suggestive of a metastasis from
clear cell renal cell carcinoma. However, no concurrent renal lesions were noted on computed tomographic
evaluation at that time. Then, four months after lung resection, he presented with a subcutaneous mass in the left
loin, as well as right loin discomfort. Computed tomography scanning revealed a 10 cm right renal mass, with
renal vein and inferior vena cava invasion, as well as recurrent disease in the right thorax. Histological examination
of the excised subcutaneous mass revealed a high-grade carcinoma consistent with clear cell renal cell carcinoma.
Conclusions: This is the first reported case of prechronous metastasis of renal cell carcinoma, with metastatic
disease manifesting prior to the development of the primary lesion. The underlying mechanism is uncertain, but
our patient’s case provides anecdotal support for the early dissemination model of metastasis.
Introduction
Although metastatic carcinoma in the presence of an
occult primary is well recognized as a common clinical
scenario of ‘carcinoma of unknown primary’ [1], under-
lying reasons for the failure of a primary tumor to mani-
fest are uncertain. Possible explanations have ranged
from spontaneous regression of the primary to an early
metastasis. We report a case of ‘prechronous’ metastasis
(see Discussion) arising from clear cell renal cell carci-
noma (RCC), with the primary lesion manifesting only
after the metastatic lesion was resected.
Case presentation
A 43-year-old Malay man presented to our facility with
a three-month history of fever, non-productive cough
and weight loss. He was a chronic smoker and had no
significant medical history. Results of a physical exami-
nation were unremarkable. A chest radiograph revealed
a large right lower zone lung lesion, and a subsequent
computed tomography (CT) scan of the thorax and
abdomen revealed a large heterogeneously enhancing
soft tissue mass in the right lower lobe of the lung with
intra-cavitary extension into the left atrium via the right
inferior pulmonary vein (Figure 1). Transthoracic needle
aspiration of this mass was suggestive of carcinoma.
Surgery was performed for the resection of this mass; a
right posterior lateral thoracotomy was performed, fol-
lowed by a right lower lobectomy. The left atrium was
opened at the inferior part of the superior pulmonary
vein and the tumor resected with a small cuff of left
atrium. The entire tumor and right lower lobe was
delivered en bloc, and the left atrial defect subsequently
patched. Histology demonstrated a high-grade clear cell
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renal cell carcinoma, a diagnosis specifically considered
by the pathologist. On immunohistochemistry, the
lesion was focally positive for epithelial membrane anti-
gen (EMA), CD10 and vimentin, but negative for anticy-
tokeratin CAM5.2, thyroid transcription factor-1 (TTF-
1), smooth muscle actin (SMA), S100, HMB-45, Melan-
A, Hepar and synaptophysin. However, as no renal
lesion was evident on the CT scan (Figure 1), a diagno-
sis of alveolar soft part sarcoma was considered. An
additional extensive investigation did not reveal a pri-
mary lesion or any other metastatic lesions.
Then, four months later, our patient developed a sub-
cutaneous mass in his left loin. A CT scan of the abdo-
men confirmed a large 11 cm tumor occupying nearly
the entire right kidney with involvement of the pelvica-
lyceal system and proximal ureter (Figure 2). The tumor
also extended into the right renal vein and the inferior
vena cava, with a 2 cm soft tissue nodule was seen in
the subcutaneous layer of the left flank. Further imaging
of the thorax demonstrated multiple lung nodules, a
large right pleural-based mass and an enlarged subcar-
inal lymph node. A bone scan was performed, and sug-
gested involvement of the right humeral head and
multiple thoracic vertebrae. Excision biopsy of the sub-
cutaneous nodule was performed, and histology
demonstrated a tumor morphologically similar to the
initially resected lung lesion, suggestive of a high-grade
clear cell renal cell carcinoma with sarcomatoid differ-
entiation (Figure 3). On immunohistochemistry, the
tumor was strongly positive for vimentin, CD10, focally
positive for epithelial membrane antigen, melan-A and
negative for TTF-1, S100, inhibin and synaptophysin
(Figure 4) The positive vimentin and negative inhibin
results weighed against the likelihood of an adrenocorti-
cal tumor.
Our patient was given palliative first-line therapy of
sunitinib, with initial best response of stable disease.
After three cycles of sunitinib, the disease progressed;
Figure 1 Computed tomography (CT) coronal view of our
patient’s thorax and abdomen, showing a large right lower
lobe lesion (arrow). As shown here, the kidneys were free of any
lesions.
Figure 2 Computed tomography (CT) coronal view of our
patient’s thorax and abdomen, showing a large right renal cell
carcinoma (arrow) 4 months later. This image is in the same
coronal cut as Figure 1, as can be seen from evaluation of the
vertebral column.
Figure 3 Histology of the lung tumor showing a clear cell
malignancy at (a) 20 × magnification and (b) 40 ×
magnification.
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tually died 13 months after his initial lung resection.
Discussion
About 25% to 30% of patients with RCC present with
metastatic disease at diagnosis but less than 5% have
solitary metastasis. Tumors with sarcomatoid change
often have poorer prognosis. Our patient presented initi-
ally with a symptomatic metastasis in the absence of an
evident primary; the primary tumor manifested only
subsequently following metastatectomy. This phenom-
enon has been reported once before in the setting of
lung cancer, where a 51-year-old woman presented with
symptomatic brain metastasis [2], where the lung pri-
mary was eventually detected in the left upper lobe five
years after resection. We sought a term to best describe
this phenomenon. The terms ‘synchronous metastasis’
and ‘metachronous metastasis’ are well understood in
terms of timing relative to the development of the pri-
mary tumor. The former term refers to a concurrent
manifestation of metastasis and primary tumor, whereas
‘metachronous’ refers to the subsequent development of
metastasis. Using a similar Greek prefix, the term ‘pre-
chronous’ clearly describes the phenomenon observed
here, where a metastatic lesion manifests prior to the
primary lesion. Ours represents the first such report of
this phenomenon in renal cell carcinoma, and we briefly
discuss possible hypotheses here that may underpin this.
In the standard late dissemination model of metasta-
sis, the metastatic cascade [3] is a multi-step sequential
process in which cancer cells depart from the primary
tumor and enter the lymphatics, blood or body cavity.
They deposit at nearby or distant sites before proliferat-
ing to colonize ectopic tissues. It is recognized that
metastases have a predilection for certain sites [4] and
require that these key sites be first seeded [3]. However,
there has been recent evidence to support aspects of the
early dissemination model, where metastasis occurs
early in the life cycle of carcinogenesis. Podsypanina et
al. engineered untransformed mouse mammary cells to
express inducible oncogenes transgenes that are able to
bypass the primary site and phenotypically show up at
secondary sites [5]. Kaplan et al.a l s os h o w e dt h a tc a n -
cer cells in murine models may relay signals, involving
vascular endothelial growth factor receptor 1 (VEGFR1)
and fibronectin, to bone marrow cells to migrate to dis-
tant organs to establish an environment amenable to
metastasis [6]. This phenomenon preceded the forma-
tion of micrometastatic colonies in these organs by four
to six days. Our case report provides anecdotal but
direct support for the early dissemination model of
metastasis.
There are some clinical similarities between our case
report as described, and the phenomenon of ‘burned-
out’ cancers seen most commonly in germ cell tumors.
In the clinical setting of patients with ‘burned-out’ germ
cell tumors, metastatic lesions are first identified in the
presence of regressed primary tumors, the latter diag-
nosed by a distinct histological appearance [7,8]. How-
ever, our case report differs in demonstrating a clear
aggressive behavior for the primary tumor upon clinical
manifestation post-metastatectomy, with radiological
growth from undetectable to an 11 cm lesion over four
months, which is inconsistent with a ‘burned-out’
primary.
Conclusions
We report a case of sarcomatoid clear cell RCC, demon-
strating the rare phenomenon of prechronous metasta-
sis. Our report provides direct support for the early
dissemination model of metastasis.
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Figure 4 (a) Hematoxylin and eosin staining of the resected
subcutaneous nodule; (b) immunostaining for CD10, (c)
epithelial membrane antigen. and (d) vimentin. Magnification is
20 × for all images.
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